"Hydroxyprogesterones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.
Descriptor ID |
D006908
|
MeSH Number(s) |
D04.210.500.745.745.654.829.395 D06.472.334.851.687.750.478
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hydroxyprogesterones".
Below are MeSH descriptors whose meaning is more specific than "Hydroxyprogesterones".
This graph shows the total number of publications written about "Hydroxyprogesterones" by people in this website by year, and whether "Hydroxyprogesterones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxyprogesterones" by people in Profiles.
-
Boelig RC, Schoen CN, Frey H, Gimovsky AC, Springel E, Backley S, Berghella V. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial. Am J Obstet Gynecol. 2022 05; 226(5):722.e1-722.e12.
-
Della Torre M, Enakpene C, Ravangard S, DiGiovanni L, Deyo K, Whelan A, Sutherland M, Fischer J. Pharmacokinetics of 17 alpha hydroxyprogesterone caproate in singleton pregnancy and its influence of maternal body size measures. Am J Obstet Gynecol MFM. 2019 11; 1(4):100051.
-
Hydery T, Price MK, Greenwood BC, Takeshita M, Kunte PS, Mauro RP, Lenz K, Jeffrey PL. Evaluation of Progesterone Utilization and Birth Outcomes in a State Medicaid Plan. Pharmacotherapy. 2017 Oct; 37(10):1328-1334.
-
Stetson B, Hibbard JU, Wilkins I, Leftwich H. Outcomes With Cerclage Alone Compared With Cerclage Plus 17a-Hydroxyprogesterone Caproate. Obstet Gynecol. 2016 11; 128(5):983-988.
-
Schoen CN, Tabbah S, Iams JD, Caughey AB, Berghella V. Why the United States preterm birth rate is declining. Am J Obstet Gynecol. 2015 Aug; 213(2):175-80.
-
Lashansky G, Saenger P, Fishman K, Gautier T, Mayes D, Berg G, Di Martino-Nardi J, Reiter E. Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab. 1991 Sep; 73(3):674-86.
-
Morris AH, Reiter EO, Geffner ME, Lippe BM, Itami RM, Mayes DM. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche. J Clin Endocrinol Metab. 1989 Oct; 69(4):709-15.
-
Reiter EO, Duckett GE, Root AW. Responses to constant infusion of LH-RH in girls with primary hypogonadism. Obstet Gynecol. 1980 Sep; 56(3):339-43.
-
Reiter EO, Fuldauer VG, Root AW. Effect of infusion of gonadotropin releasing hormone upon plasma concentrations of sex hormones in prepubertal and pubertal males. Steroids. 1976 Dec; 28(6):829-35.
-
Reiter EO, Kaplan SL, Conte FA, Grumbach MM. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate. Pediatr Res. 1975 Feb; 9(2):111-6.